A highly competitive, ever-changing market requires the right tools and the best resources available to make a good strategy into a brilliant launch. Discover the key elements to maximizing a modern drug launch.
The changing health care landscape requires innovative, data-driven approaches to drug launches. The one-size-fits all approach to launching a blockbuster drug every other year is now giving way to smaller, more frequent tailored launches of pipeline drugs.
Small shifts in categorization methods and marketing perceptions can very well make the difference between a successful drug launch and a failing one. It is without a doubt a time of patient-centric approaches to marketing and data analysis in the pharmaceutical industry, and this applies to the way we organize and categorize our data sets as well.
Two-thirds of all launches fall short of expectations, according to McKinsey.
It is a fast-changing, dangerous market out there, and as companies can no longer rest under past blockbusters, everybody needs to learn how to adjust to today’s high intensity launch environment.
When launches become increasingly numerous, smaller and more competitive, pressure will only continue to rise as launches in the coming years are expected to increase in more than 100% from 2005.